Skip to main content

Annapolis dermatology company Alphyn Biologics raises $3.3M, plans $17.5M round

Alphyn Biologics is planning on using its new funding for a clinical trial for its new eczema treatment.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.